ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form 6-K — Sep 28, 2026
Ascentage Pharma disclosed that its RSU scheme trustee bought 50,000 shares on-market for ~HK$1.43 million (avg ~HK$28.56) on September 28, 2026, bringing trustee-held shares to 2,715,000. Separately, Chairman and CEO Dr. Yang Dajun acquired 38,630 shares on-market between September 23-25, 2026 for ~HK$1.16 million at ~HK$29.95 per share, raising his deemed interest to 62,570,254 shares, approximately 16.69% of issued capital.
Key figures
- Trustee avg price hkd
- HK$28.56
- Chairman avg price hkd
- HK$29.95
- Chairman shares acquired
- 38630
- Trustee purchased shares
- 50000
- Trustee total shares held
- 2715000
- Chairman ownership percent
- 16.69%
- Chairman total interested shares
- 62570254
- Trustee purchase consideration hkd
- 1428000
- Chairman purchase consideration hkd
- 1157137
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.